Fundraising Fox

Biotech Investors & VC Firms in China

202 firms in this list, with a median first check of $1.1M. 30 of them lead rounds. Generated from verified public data and updated continuously.

New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
72 people
F-Prime Capital
CambridgePre-Seed–Late Stage$3M – $10M
110 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
47 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage$100K – $50M
46 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
40 people
Advent International
BostonSeries A–Late Stage$1.1B
61 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
30 people
Artesian
SydneyPre-Seed–Late Stage$20M
39 people
Celesta Capital
Menlo ParkSeed–Late Stage$5M – $20M
33 people
AEF Greater Bay Area Fund
Hong KongSeed–Series B$2.5M – $28M
57 people
Eight Roads Ventures
MumbaiSeed–Late Stage$5M – $30M
20 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
22 people
Prosperity7 Ventures
DhahranSeries A–Growth
41 people
Vertex Ventures China
SingaporePre-Seed–Late Stage$2M – $85M
8 people
Decheng Capital
Menlo ParkSeed–Growth
19 people
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
19 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
K3 Ventures
SingaporeSeed–Growth$1.2M – $42M
23 people
Panacea Venture
SingaporePre-Seed–Late Stage
22 people
WI Harper Group
San FranciscoSeed–Series C$5M – $15M
24 people
Samsung Ventures
SeoulSeed–Late Stage
26 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
7 people
Beyond Ventures
Hong KongSeed–Growth$720K – $138M
16 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.